{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:26:38Z","timestamp":1787225198006,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jtct.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:39:34Z","timestamp":1713281974000},"page":"690.e1-690.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-3221","authenticated-orcid":false,"given":"Gabriel","family":"Salinas Cisneros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-3952","authenticated-orcid":false,"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel","family":"Long-Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A.","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-1594","authenticated-orcid":false,"given":"Lena E.","family":"Winestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeen","family":"Dara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-0358","authenticated-orcid":false,"given":"James N.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-2679","authenticated-orcid":false,"given":"Michelle L.","family":"Hermiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3351-3278","authenticated-orcid":false,"given":"Matt","family":"Zinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jtct.2024.04.006_bib0001","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2024.04.006_bib0002","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0268-960X(03)00002-X","article-title":"Veno-occlusive disease: cytokines, genetics, and haemostasis","volume":"17","author":"Coppell","year":"2003","journal-title":"Blood Rev"},{"issue":"1 Suppl","key":"10.1016\/j.jtct.2024.04.006_bib0004","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.bbmt.2012.10.023","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions","volume":"19","author":"Richardson","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1 Suppl 1","key":"10.1016\/j.jtct.2024.04.006_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.04.006_bib0006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.006_bib0007","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.16557","article-title":"Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS\/VOD after haematopoietic cell transplantation","volume":"190","author":"Cairo","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.006_bib0008","first-page":"5","article-title":"Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia","volume":"55","author":"Jacobs","year":"1979","journal-title":"S Afr Med J"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.006_bib0009","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jtct.2024.04.006_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.006_bib0012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41409-020-00998-w","article-title":"Improved detection of sinusoidal obstructive syndrome using pediatric-AYA diagnostic criteria and severity grading","volume":"56","author":"Ragoonanan","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2024.04.006_bib0013","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/s41409-020-0918-1","article-title":"Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting?: prospective evaluation of pediatric EBMT criteria for VOD","volume":"55","author":"Szmit","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2024.04.006_bib0014","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa2206575","article-title":"Lentiviral gene therapy for artemis-deficient SCID","volume":"387","author":"Cowan","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jtct.2024.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.006_bib0016","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood.2020009342","article-title":"A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation","volume":"137","author":"Qayed","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0017","doi-asserted-by":"crossref","first-page":"123.e1","DOI":"10.1016\/j.jtct.2022.11.019","article-title":"Adapting the HCT-CI definitions for children, adolescents, and young adults with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation","volume":"29","author":"Friend","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2024.04.006_bib0018","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","article-title":"Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation","volume":"24","author":"Toh","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"12 Pt 1","key":"10.1016\/j.jtct.2024.04.006_bib0019","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.006_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.006_bib0022","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1038\/s41598-018-26033-z","article-title":"The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation","volume":"8","author":"El-Serafi","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cts.12709","article-title":"Reduced risk of sinusoidal obstruction syndrome of the liver after busulfan-cyclophosphamide conditioning prior to allogeneic hematopoietic stem cell transplantation","volume":"13","author":"El-Serafi","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0024","doi-asserted-by":"crossref","first-page":"e27518","DOI":"10.1002\/pbc.27518","article-title":"Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine","volume":"66","author":"Lee","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2024.04.006_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.bmt.1704143","article-title":"N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation","volume":"32","author":"Sjoo","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2024.04.006_bib0026","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/pbc.24351","article-title":"131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma","volume":"60","author":"French","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.006_bib0027","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.2005.03.6400","article-title":"Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study","volume":"24","author":"Matthay","year":"2006","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2024.04.006_bib0028","doi-asserted-by":"crossref","first-page":"e29117","DOI":"10.1002\/pbc.29117","article-title":"A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study","volume":"68","author":"Weiss","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"9823","key":"10.1016\/j.jtct.2024.04.006_bib0029","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jtct.2024.04.006_bib0030","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program","volume":"22","author":"Corbacioglu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"10.1016\/j.jtct.2024.04.006_bib0031","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.006_bib0032","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbmt.2020.03.011","article-title":"Incidence of anicteric veno-occlusive disease\/sinusoidal obstruction syndrome and outcomes with defibrotide following hematopoietic cell transplantation in adult and pediatric patients","volume":"26","author":"Corbacioglu","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.04.006_bib0033","doi-asserted-by":"crossref","first-page":"e28412","DOI":"10.1002\/pbc.28412","article-title":"Prognosis of pediatric patients with anicteric and late-onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"67","author":"Inagaki","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2024.04.006_bib0034","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1182\/blood-2022-162755","article-title":"Outcomes of defibrotide-treated patients with anicteric\/icteric veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) after hematopoietic cell transplantation (HCT): results from the defifrance registry study","volume":"140","author":"Gandemer","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.006_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/bloodadvances.2021005410","article-title":"Defibrotide: real-world management of veno-occlusive disease\/sinusoidal obstructive syndrome after stem cell transplant","volume":"6","author":"Nauffal","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.006_bib0036","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00330-017-5137-9","article-title":"Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation","volume":"28","author":"Park","year":"2018","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020291","article-title":"Endothelial dysfunction in obesity-induced inflammation: molecular mechanisms and clinical implications","volume":"10","author":"Kwaifa","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.006_bib0038","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41430-021-00977-4","article-title":"Inflammation as a diagnostic criterion in the GLIM definition of malnutrition\u2014what CRP-threshold relates to reduced food intake in older patients with acute disease?","volume":"76","author":"Pourhassan","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jtct.2024.04.006_bib0039","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.jtct.2024.04.006_bib0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jtct.2022.01.013","article-title":"Association between the magnitude of intravenous busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation","volume":"28","author":"Bognar","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2024.04.006_bib0041","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0042","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejrad.2009.03.052","article-title":"Portal venous diameter in children: normal limits according to age, weight and height","volume":"75","author":"Soyupak","year":"2010","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.006_bib0043","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.006_bib0044","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41409-019-0705-z","article-title":"Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a position statement from an international expert group","volume":"55","author":"Mohty","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.04.006_bib0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2019.11642","article-title":"Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial","volume":"322","author":"Park","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.006_bib0046","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40261-022-01140-y","article-title":"A systematic review and meta-analysis of studies of defibrotide prophylaxis for veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"42","author":"Corbacioglu","year":"2022","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.jtct.2024.04.006_bib0047","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S2352-3026(23)00011-X","article-title":"Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial","volume":"10","author":"Grupp","year":"2023","journal-title":"Lancet Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2024.04.006_bib0048","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41409-023-02007-2","article-title":"Prevention of veno-occlusive disease\/sinusoidal obstruction syndrome: a never-ending story and no easy answer","volume":"58","author":"Corbacioglu","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.006_bib0049","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724003452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724003452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:17:45Z","timestamp":1751368665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724003452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2666636724003452"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.04.006","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}